Literature DB >> 20484577

Generation of retinal ganglion-like cells from reprogrammed mouse fibroblasts.

Mengfei Chen1, Qin Chen, Xuerong Sun, Wenjuan Shen, Bingqian Liu, Xiufeng Zhong, Yunxia Leng, Chunmei Li, Weizhong Zhang, Fang Chai, Bing Huang, Qianying Gao, Andy Peng Xiang, Yehong Zhuo, Jian Ge.   

Abstract

PURPOSE: Somatic cells can be reprogrammed into an embryonic stem cell-like pluripotent state by Oct-3/4, Sox2, c-Myc, and Klf4. Sox2 as an essential reprogramming factor also contributes to the development of the eye and the retina. This study was conducted to determine whether induced pluripotent stem (iPS) cells express retinal progenitor cell (RPC)-related genes and whether iPS cells can directly differentiate into retinal ganglion cells (RGCs).
METHODS: Mouse iPS cells were induced by the ectopically expressed four factors in tail-tip fibroblasts (TTFs). The expression of RPC-related genes in iPS cells was analyzed by RT-PCR and immunofluorescence. iPS cells were induced to differentiate into RGCs by the addition of Dkk1 + Noggin (DN) + DAPT and overexpression of Math5. iPS-derived retinal ganglion (RG)-like cells were injected into the retina, and the eyes were analyzed by immunohistochemistry.
RESULTS: iPS cells inherently express RPC-related genes such as Pax6, Rx, Otx2, Lhx2, and Nestin. Overexpression of Math5 and addition of DN can directly differentiate iPS into retinal ganglion-like cells. These iPS-derived RG-like cells display long synapses and gene expression patterns, including Math5, Brn3b, Islet-1, and Thy1.2. Furthermore, inhibiting Hes1 by DAPT increases the expression of RGC marker genes. In addition, iPS-derived RG-like cells were able to survive but were unable to be integrated into the normal retina after transplantation.
CONCLUSIONS: The four factor iPS cell inherently expressed RPC-related genes, and the iPS cell could be further turned into RG-like cells by the regulation of transcription factor expression. These findings demonstrate that iPS cells are valuable for regeneration research into retinal degeneration diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484577     DOI: 10.1167/iovs.09-4504

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  38 in total

Review 1.  Stemming vision loss with stem cells.

Authors:  Valentina Marchetti; Tim U Krohne; David F Friedlander; Martin Friedlander
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 2.  Stem cell therapies for retinal diseases: recapitulating development to replace degenerated cells.

Authors:  Cuiping Zhao; Qingjie Wang; Sally Temple
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

Review 3.  Development of gene and stem cell therapy for ocular neurodegeneration.

Authors:  Jing-Xue Zhang; Ning-Li Wang; Qing-Jun Lu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

4.  Continuous non-cell autonomous reprogramming to generate retinal ganglion cells for glaucomatous neuropathy.

Authors:  Sowmya Parameswaran; Shashank Manohar Dravid; Pooja Teotia; Raghu R Krishnamoorthy; Fang Qiu; Carol Toris; John Morrison; Iqbal Ahmad
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

5.  Retinoid acid and taurine promote NeuroD1-induced differentiation of induced pluripotent stem cells into retinal ganglion cells.

Authors:  Li Huang; Mengfei Chen; Weizhong Zhang; Xuerong Sun; Bingqian Liu; Jian Ge
Journal:  Mol Cell Biochem       Date:  2017-08-01       Impact factor: 3.396

Review 6.  The emerging role of stem cells in ocular neurodegeneration: hype or hope?

Authors:  Neeru Jindal; Asok Mukhopadhyay; Akshay Anand
Journal:  Mol Cell Biochem       Date:  2012-06       Impact factor: 3.396

7.  Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses.

Authors:  M Joseph Phillips; Kyle A Wallace; Sarah J Dickerson; Michael J Miller; Amelia D Verhoeven; Jessica M Martin; Lynda S Wright; Wei Shen; Elizabeth E Capowski; E Ferda Percin; Enio T Perez; Xiufeng Zhong; Maria V Canto-Soler; David M Gamm
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-18       Impact factor: 4.799

Review 8.  Retinal repair with induced pluripotent stem cells.

Authors:  Shomoukh Al-Shamekh; Jeffrey L Goldberg
Journal:  Transl Res       Date:  2013-11-08       Impact factor: 7.012

9.  Chemically induced specification of retinal ganglion cells from human embryonic and induced pluripotent stem cells.

Authors:  Hamidreza Riazifar; Yousheng Jia; Jing Chen; Gary Lynch; Taosheng Huang
Journal:  Stem Cells Transl Med       Date:  2014-02-03       Impact factor: 6.940

Review 10.  Stem cells, retinal ganglion cells and glaucoma.

Authors:  Valentin M Sluch; Donald J Zack
Journal:  Dev Ophthalmol       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.